Molecular Approaches and Modern Clinical Strategies for the Management of Helicobacter pylori Infection in Japan

  • Suzuki Hidekazu
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan
  • Nishizawa Toshihiro
    Division of Gastroenterology, National Hospital Organization, Tokyo Medical Center, Tokyo, Japan
  • Tsugawa Hitoshi
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan
  • Hibi Toshifumi
    Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan

書誌事項

タイトル別名
  • Molecular Approaches and Modern Clinical Strategies for the Management of <b><i>Helicobacter pylori</i></b> Infection in Japan

この論文をさがす

抄録

Thirty years have passed since Warren and Marshall’s discovery of Helicobacter pylori (H.pylori). Since then, not only peptic ulcer diseases and chronic gastritis but also non-cardia gastric cancers have been recognized as diseases originating from H. pylori infection. Several combination therapies consisting of multiple antibiotics have been developed as first- or second-line regimens to eradicate H. pylori infection. Our extensive experience in the field of anti-H. pylori medicine suggests that clinicians should consider a possible role for unidentified, invisible pathogens to elucidate the pathogenesis and improve the treatment of refractory diseases of unknown etiology.

収録刊行物

被引用文献 (5)*注記

もっと見る

参考文献 (112)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ